Efficacy and safety of gemcitabine-docetaxel combination therapy for recurrent or refractory high-grade osteosarcoma in China: a retrospective study of 18 patients.

Efficacy and safety of gemcitabine-docetaxel combination therapy for recurrent or refractory high-grade osteosarcoma in China: a retrospective study of 18 patients.

Item
http://www.wikidata.org/entity/Q33400419
Osteosarcoma in Korean children and adolescentsComparison of pemetrexed plus cisplatin with gemcitabine plus docetaxel in refractory/metastatic osteosarcoma: Clinical outcomes from a retrospective database monitored in a single instituteDocetaxel, bevacizumab, and gemcitabine for very high risk sarcomas in adolescents and young adults: A single-center experience.Treatment pathway of bone sarcoma in children, adolescents, and young adultsLong-term response of gemcitabine plus docetaxel chemotherapy regimen for extraskeletal osteosarcoma: A case reportGemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of boneFeasibility and efficacy of gemcitabine and docetaxel combination chemotherapy for bone and soft tissue sarcomas: multi-institutional retrospective analysis of 134 patients.The role of chemotherapy for metastatic, relapsed and refractory osteosarcoma.Advances in emerging drugs for osteosarcoma.Higher Gemcitabine Dose Was Associated With Better Outcome of Osteosarcoma Patients Receiving Gemcitabine-Docetaxel Chemotherapy.Radiotherapy and gemcitabine-docetaxel chemotherapy in children and adolescents with unresectable recurrent or refractory osteosarcoma.Gemcitabine and docetaxel for the treatment of children and adolescents with recurrent or refractory osteosarcoma: Korea Cancer Center Hospital experience.Gemcitabine plus sirolimus for relapsed and progressing osteosarcoma patients after standard chemotherapy: a multicenter, single-arm phase II trial of Spanish Group for Research on Sarcoma (GEIS).Progress in the chemotherapeutic treatment of osteosarcoma
P2860

Efficacy and safety of gemcitabine-docetaxel combination therapy for recurrent or refractory high-grade osteosarcoma in China: a retrospective study of 18 patients.

Item
http://www.wikidata.org/entity/Q33400419
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Efficacy and safety of gemcita ...... spective study of 18 patients.
@ast
Efficacy and safety of gemcita ...... spective study of 18 patients.
@en
type
label
Efficacy and safety of gemcita ...... spective study of 18 patients.
@ast
Efficacy and safety of gemcita ...... spective study of 18 patients.
@en
prefLabel
Efficacy and safety of gemcita ...... spective study of 18 patients.
@ast
Efficacy and safety of gemcita ...... spective study of 18 patients.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Efficacy and safety of gemcita ...... spective study of 18 patients.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698